Skip to main content
NCBI home page
Cytotechnology logoLink to Cytotechnology
. 2002 Nov;40(1-3):67–73. doi: 10.1023/A:1023966121989

Oral administration of milk fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1 to DBA/1 mice inhibits secretion of proinflammatory cytokines

Hiroshi Kano 1,✉, Orie Mogami 1, Masayuki Uchida 1
PMCID: PMC3449529  PMID: 19003106

Abstract

We have previously shown that oral administration of skimmed milk(SM) fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1 (OLL1073R-1/SM) to DBA/1 mice inhibited the development of collagen-induced arthritis (CIA). In this study, our aim was to examine possible mechanisms of inhibiting the development of CIA. We studied the effect of OLL1073R-1/SM on cytokine secretion from cells of popliteal lymph nodes (lymph node cells; LNC) of mice. The results showed that feeding OLL1073R-1/SM inhibited secretion of proinflammatory cytokines such as interferon γ (IFN-γ), interleukin 6 (IL-6), tumor necrosis factor α (TNF-α) and the chemokine, monocyte chemoattractant protein 1 (MCP-1). The most prominent effect was inhibition of TNF-α. Secretion of IL-2 and IL-4 were not influenced. Feeding OLL1073R-1/SM inhibited secretion of proinflammatory cytokines produced by accessory cells, but not T cells. We conclude that CIA may be prevented via down regulation of secretion of proinflammatory cytokines such as IL-6, TNF-α and IFN-γ, and of the chemokine of MCP-1.

Keywords: interferon γ, interleukin 6, Lactobacillus bulgaricus OLL1073R-1, proinflammatory cytokines, tumor necrosis factor α

Full Text

The Full Text of this article is available as a PDF (155.4 KB).

References

  1. Alonzi T, Fattori E, Lazzaro D, Costa P, Probert L, Kollias G, Benedetti FD, Poli V, Ciliberto G. Interleukin 6 is required for the development of collagen-induced arthritis. J Exp Med. 1998;187:461–468. doi: 10.1084/jem.187.4.461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Boissier MC, Chiocchia G, Bessis N, Hajnal J, Garotta G, Nicoletti F, Fournier C. Biphasic effect of interferon-γ in murine collagen-induced arthritis. Eur J Immunol. 1995;25:1184–1196. doi: 10.1002/eji.1830250508. [DOI] [PubMed] [Google Scholar]
  3. Cooper SM, Sriram S, Ranges GE. Suppression of murine collagen-induced arthritis with monoclonal anti-Ia antibodies and augmentation with IFN-γ. J Immunol. 1988;141:1958–1962. [PubMed] [Google Scholar]
  4. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol. 1996;14:397–440. doi: 10.1146/annurev.immunol.14.1.397. [DOI] [PubMed] [Google Scholar]
  5. Haller D, Blum S, Bode C, Hammes WP, Schiffrin EJ. Activation of human peripheral blood mononuclear cells by non-pathogenic bacteria in vitro: Evidence of NK cells as primary targets. Infect Immun. 2000;68:752–759. doi: 10.1128/IAI.68.2.752-759.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Joosten LAB, Helsen MMA, Saxne T, Van de Loo FAJ, Heinegård D, Van den Berg WB. IL-1αβ blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-α blockade only ameliorates joint inflammation. J Immunol. 1999;163:5049–5055. [PubMed] [Google Scholar]
  7. Joosten LAB, Helsen MMA, Van de Loo FAJ, Van den Berg WB. Anticytokine treatment of established type II collageninduced arthritis in DBA/1 mice. Arthritis Rheum. 1996;39:797–809. doi: 10.1002/art.1780390513. [DOI] [PubMed] [Google Scholar]
  8. Kano H, Kaneko T, Kaminogawa S. Oral intake of Lactobacillus delbrueckii subsp. bulgaricus OLL1073R-1 prevents collagen-induced arthritis in mice. J Food Prot. 2002;65:153–160. doi: 10.4315/0362-028x-65.1.153. [DOI] [PubMed] [Google Scholar]
  9. Kato I, Endo-Tanaka K, Yokokura T. Suppressive effects of the oral administration of Lactobacillus casei on type II collagen-induced arthritis in DBA/1 mice. Life Sciences. 1998;63:635–644. doi: 10.1016/S0024-3205(98)00315-4. [DOI] [PubMed] [Google Scholar]
  10. Kitazawa H, Itoh T, Tomioka Y, Mizugaki M, Yamaguchi T. Induction of IFN-α and IL-1α production in macrophages stimulated with phosphopolysaccharide produced by Lactococcus lactis ssp. cremoris. Int J Food Microbiol. 1996;31:99–106. doi: 10.1016/0168-1605(96)00968-3. [DOI] [PubMed] [Google Scholar]
  11. Marin ML, Tejada-Simon MV, Murtha J, Ustunol Z, Pestka JJ. Effects of Lactobacillus spp. on cytokine production by RAW264.7 macrophage and EL-4 thymoma cell lines. J Food Prot. 1997;60:1364–1370. doi: 10.4315/0362-028X-60.11.1364. [DOI] [PubMed] [Google Scholar]
  12. Matsuzaki T, Yamazaki R, Hashimoto S, Yokokura T. The effect of oral feeding of Lactobacillus casei strain Shirota on immunoglobulin E production in mice. J Dairy Sci. 1998;81:48–53. doi: 10.3168/jds.S0022-0302(98)75549-3. [DOI] [PubMed] [Google Scholar]
  13. Mauritz NJ, Holmdahl R, Jonsson R, Van der Meide PH, Scheynius A, Klareskog L. Treatment with gamma-interferon triggers the onset of collagen arthritis in mice. Arthritis Rheum. 1988;31:1297–1304. doi: 10.1002/art.1780311012. [DOI] [PubMed] [Google Scholar]
  14. Miettinen M, Matikainen S, Vuopio-Varkila J, Pirhonen J, Varkila K, Kurimoto M, Julkunen I. Lactobacilli and Streptococci induce interleukin-12 (IL-12), IL-18, and gamma interferon production in human peripheral blood mononuclear cells. Infect Immun. 1998;66:6058–6062. doi: 10.1128/iai.66.12.6058-6062.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today. 1996;17:138–146. doi: 10.1016/0167-5699(96)80606-2. [DOI] [PubMed] [Google Scholar]
  16. Onozaki K, Matsushima K, Aggarwal B, Oppenheim JJ. Human interleukin-1 is a cytocidal factor for several tumor cell lines. J Immunol. 1985;135:3962–3968. [PubMed] [Google Scholar]
  17. Orme IM, Cooper AM. Cytokine/chemokine cascades in immunity to tuberculosis. Immunol Today. 1999;20:307–312. doi: 10.1016/S0167-5699(98)01438-8. [DOI] [PubMed] [Google Scholar]
  18. Parks E, Strieter R, ukacs NW, Gauldie J, Hitt M, Graham FL, Kunkel SL. Transient gene transfer of IL-12 regulates chemokine expression and disease severity in experimental arthritis. J Immunol. 1998;160:4615–4619. [PubMed] [Google Scholar]
  19. Ramsay AJ, Ruby J, Ramshaw IA. A case for cytokines as effector molecules in the resolution of virus infection. Immunol Today. 1993;14:155–157. doi: 10.1016/0167-5699(93)90277-R. [DOI] [PubMed] [Google Scholar]
  20. Rangavajhyala N, Shahani KM, Sridevi G, Srikumaran S. Nonlipopolysaccharide component(s) of Lactobacillus acidophilus stimulate(s) the production of interleukin-1α and tumor necrosis factor-α by murine macrophages. Nutr Cancer. 1997;28:130–134. doi: 10.1080/01635589709514564. [DOI] [PubMed] [Google Scholar]
  21. Sato K, Saito H, Tomioka H. Enhancement of host resistance against Listeria infection by Lactobacillus casei: Activation of liver macrophages and peritoneal macrophages by Lactobacillus casei. Microbiol Immunol. 1988;32:689–698. doi: 10.1111/j.1348-0421.1988.tb01430.x. [DOI] [PubMed] [Google Scholar]
  22. Solis-Pereyra B, Aattouri N, Lemonnier D. Role of food in the stimulation of cytokine production. Am J Clin Nutr. 1997;66:521S–525S. doi: 10.1093/ajcn/66.2.421S. [DOI] [PubMed] [Google Scholar]
  23. Solis-Pereyra B, Lemonnier D. Induction of human cytokines by bacteria used in dairy foods. Nutr Res. 1993;13:1127–1140. doi: 10.1016/S0271-5317(05)80737-7. [DOI] [Google Scholar]
  24. Thornton S, Boivin GP, Kim KN, Finkelman FD, Hirsch R. Heterogeneous effects of IL-2 on collagen-induced arthritis. J Immunol. 2000;165:1557–1563. doi: 10.4049/jimmunol.165.3.1557. [DOI] [PubMed] [Google Scholar]
  25. Trinchieri G, Wysocka M, D'Andrea A, Rengaraju M, Aste-Amezaga M, Kubin M, Valiante NM, Chehimi J. Natural killer cell stimulatory factor (NKSF) or interleukin-12 is a key regulator of immune response and inflammation. Prog Growth Factor Res. 1992;4:355–368. doi: 10.1016/0955-2235(92)90016-B. [DOI] [PubMed] [Google Scholar]
  26. Urban JL, Shephard HM, Rothstein JL, Sugarman BJ, Schreiber H. Tumor necrosis factor: A potent effector molecule for tumor cell killing by activated macrophages. Proc Natl Acad Sci USA. 1986;83:5233–5237. doi: 10.1073/pnas.83.14.5233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Williams RO, Feldmann M, Maini RN. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc Natl Acad Sci USA. 1992;89:9784–9788. doi: 10.1073/pnas.89.20.9784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Wooley PH, Dutcher J, Widmer MB, Gillis S. Influence of a recombinant human soluble tumor necrosis factor receptor FC fusion protein on type II collagen-induced arthritis in mice. J Immunol. 1993;151:6602–6607. [PubMed] [Google Scholar]
  29. Wooley PH, Luthra HS, Stuart JM, David CS. Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J Exp Med. 1981;154:688–700. doi: 10.1084/jem.154.3.688. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cytotechnology are provided here courtesy of Springer Science+Business Media B.V.

RESOURCES